Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Tandem Meetings 2023 | Evolution & goals of GvHD prophylaxis strategies

Name: Evolution & goals of GvHD prophylaxis strategies
Uploaded: 2023-02-16T00:00:00Z
Duration: 2 min 33 s

Rebecca Gonzalez • 16 Feb 2023

Tandem Meetings 2023

General Abatacept Anti-thymocyte globulin Antibodies Cyclophosphamide Mycophenolate mofetil Rituximab Ruxolitinib Sirolimus Tacrolimus

Rebecca Gonzalez, PharmD, BCOP, Moffitt Cancer Center, Tampa, FL, discusses the evolution of graft-versus-host disease (GvHD) prophylaxis strategies, commenting on the importance of moving towards strategies that help optimize T regulatory cell (Treg) concentrations, thus limiting both acute and chronic GvHD. This interview took place at the 2023 Transplantation & Cellular Therapy Meetings of ASTCT™ and CIBMTR® held in Orlando, FL.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.